期刊文献+

新生儿型氨甲酰磷酸合成酶Ⅰ缺乏症合并地中海贫血1例及文献复习

下载PDF
导出
摘要 目的探讨新生儿型氨甲酰磷酸合成酶Ⅰ缺乏症(CPSⅠD)的临床特点及实验室分析结果。方法收集1例CPSⅠD患者的临床资料及基因测序结果,并结合相关文献进行分析。结果患儿出生2 d即出现吮奶差,随后出现精神反应差,拒奶,嗜睡,昏迷和高氨血症,1个月后开始出现贫血;患儿外周血及其父母外周血染色体核型均显示正常,基因测序结果显示患儿为2个CPSⅠ基因变异,均位于2号染色体,分别源于父方和母方,其中c.2359(exon19)C>T是致病突变位点,c.3389(exon27)C>A基因突变位点临床意义不明;地中海贫血血红蛋白电泳检测结果Bart′s2.9,基因型诊断为SEA杂合,血串联质谱瓜氨酸显著降低。结论新生儿疾病筛查技术结合基因测序有利于疾病的早发现早诊断,新生儿起病迅速,常规治疗未见明显改善时应高度怀疑遗传代谢性疾病,并进行相应的筛查和精准确诊。
出处 《检验医学与临床》 2024年第3期414-416,共3页 Laboratory Medicine and Clinic
基金 2022年度湖北省自然科学基金创新发展联合基金项目(2022CFD070) 湖北省卫生健康委员会联合基金项目(WJ2019439) 湖北理工学院校级科研项目(21xjz08Y) 黄石市妇幼保健院2022-2023年度院级科研项目青年项目(HSMCHH2022003)。
  • 相关文献

参考文献9

二级参考文献90

  • 1蒋函,张益多,岳新爱,于凡,陈曼.血常规红细胞指标在贫血鉴别诊断中的应用价值体会[J].中国全科医学,2021,24(S01):131-133. 被引量:12
  • 2Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S., Sunyaev, S.R., 2010. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249.
  • 3Alonso, E., Cervera, J., Garcia-Espana, A., Bendala, E., Rubio, V., 1992. Oxidative inactivation of carbamoyl phosphate synthetase (ammonia). Mechanism and sites of oxidation, degradation of the oxidized enzyme, and inactivation by glycerol, EDTA, and thiol protecting agents. J. Biol. Chem. 267, 4524-4532.
  • 4Alonso, E., Rubio, V., 1995. Affinity cleavage of carbamoyl-phosphate syn- thetase I localizes regions of the enzyme interacting with the molecule of ATP that phosphorylates carbamate. Eur. J. Biochem. 229, 377-384.
  • 5Bender, D.A., 2012. Amino Acid Metabolism, third ed. Wiley-Blackwell, Oxford. Bradford, M.M., 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
  • 6Brusilow, S.W., Horwich, A.L., 2001. Urea cycle enzymes. In: Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Child, B., Kinzler, K.W., Vogelstein, B. (Eds.), The Metabolic and Molecular Bases of Inherited Disease, eighth ed. McGraw-Hill, New York, USA, pp. 1909-1963.
  • 7Case, D.A., Cheatham III, T.E., Darden, T., Gohlke, H., Luo, R., Merz Jr., K.M., Onufriev, A., Simmerling, C., Wang, B., Woods, R., 2005. The Amber biomolecular simulation programs. J. Computat. Chem. 26, 1668- 1688.
  • 8Cervera, J., Conejero-Lara, F., Ruiz-Sanz, J., Galisteo, M.L., Mateo, EL., Lusty, C.J., Rubio, V., 1993. The influence of effectors and subunit in- teractions on Escherichia coli carbamoyl-phosphate synthetase studied by differential scanning calorimetry. J. Biol. Chem. 268, 12504-12511.
  • 9Dfez-Fernfindez, C., Hu, L., Cervera, J., H/iberle, J., Rubio, V., 2014. Under- standing carbamoyl phosphate synthetase (CPS1) deficiency by using the recombinantly purified human enzyme: effects of CPS1 mutations that concentrate in a central domain of unknown function. Mol. Genet. Metab. 112, 123-132.
  • 10Dfez-FeruSXldez, C., Martfnez, A.I., Pekkala, S., Barcelona, B., P6rez- Arellano, I., Guadalajara, A.M., Summar, M., Cervera, J., Rubio, V., 2013. Molecular characterization of carbamoyl-phosphate synthetase (CPS1) deficiency using human recombinant CPS 1 as a key tool. Hum. Mutat. 34, 1149-1159.

共引文献282

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部